The global healthcare sector is witnessing unprecedented innovation in rare disease management, with IgG4-related diseases representing a crucial breakthrough area in autoimmune medicine. These multisystem inflammatory disorders, once considered medical enigmas, are now driving substantial pharmaceutical investment and therapeutic development across multiple organ systems. Defining IgG4-Related Pathology IgG4-related diseases constitute a family of fibroinflammatory conditions Read.